These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
67 related items for PubMed ID: 15322247
1. Induction of radiosensitization by indolocarbazole derivatives: the role of DNA topoisomerase I. Chen AY, Shih SJ, Hsiao M, Rothenberg ML, Prudhomme M. Mol Pharmacol; 2004 Sep; 66(3):553-60. PubMed ID: 15322247 [Abstract] [Full Text] [Related]
2. Use of camptothecin-resistant mammalian cell lines to evaluate the role of topoisomerase I in the antiproliferative activity of the indolocarbazole, NB-506, and its topoisomerase I binding site. Urasaki Y, Laco G, Takebayashi Y, Bailly C, Kohlhagen G, Pommier Y. Cancer Res; 2001 Jan 15; 61(2):504-8. PubMed ID: 11212241 [Abstract] [Full Text] [Related]
7. Indolocarbazole glycosides in inactive conformations. Facompré M, Carrasco C, Vezin H, Chisholm JD, Yoburn JC, Van Vranken DL, Bailly C. Chembiochem; 2003 May 09; 4(5):386-95. PubMed ID: 12740810 [Abstract] [Full Text] [Related]
8. Ku86 modulates DNA topoisomerase I-mediated radiosensitization, but not cytotoxicity, in mammalian cells. Shih SJ, Erbele T, Chen AY. Cancer Res; 2005 Oct 15; 65(20):9194-9. PubMed ID: 16230379 [Abstract] [Full Text] [Related]
9. DNA repair enzyme, O6-methylguanine DNA methyltransferase, modulates cytotoxicity of camptothecin-derived topoisomerase I inhibitors. Kuo CC, Liu JF, Chang JY. J Pharmacol Exp Ther; 2006 Feb 15; 316(2):946-54. PubMed ID: 16258022 [Abstract] [Full Text] [Related]
12. Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex. Staker BL, Feese MD, Cushman M, Pommier Y, Zembower D, Stewart L, Burgin AB. J Med Chem; 2005 Apr 07; 48(7):2336-45. PubMed ID: 15801827 [Abstract] [Full Text] [Related]
13. Induction of mammalian DNA topoisomerase I mediated DNA cleavage by antitumor indolocarbazole derivatives. Yamashita Y, Fujii N, Murakata C, Ashizawa T, Okabe M, Nakano H. Biochemistry; 1992 Dec 08; 31(48):12069-75. PubMed ID: 1333791 [Abstract] [Full Text] [Related]
16. Characterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cells. Jensen LH, Dejligbjerg M, Hansen LT, Grauslund M, Jensen PB, Sehested M. BMC Pharmacol; 2004 Dec 02; 4():31. PubMed ID: 15575955 [Abstract] [Full Text] [Related]
17. Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells. Dopp E, Hartmann LM, Florea AM, von Recklinghausen U, Pieper R, Shokouhi B, Rettenmeier AW, Hirner AV, Obe G. Toxicol Appl Pharmacol; 2004 Dec 01; 201(2):156-65. PubMed ID: 15541755 [Abstract] [Full Text] [Related]
18. Syntheses and biological activities of rebeccamycin analogues with uncommon sugars. Zhang G, Shen J, Cheng H, Zhu L, Fang L, Luo S, Muller MT, Lee GE, Wei L, Du Y, Sun D, Wang PG. J Med Chem; 2005 Apr 07; 48(7):2600-11. PubMed ID: 15801850 [Abstract] [Full Text] [Related]
19. Design and synthesis of N-methylmaleimide indolocarbazole bearing modified 2-acetamino acid moieties as Topoisomerase I inhibitors. Li Z, Zhai F, Zhao L, Guo Q, You Q. Bioorg Med Chem Lett; 2009 Jan 15; 19(2):406-9. PubMed ID: 19058964 [Abstract] [Full Text] [Related]
20. Design and synthesis of N-(pyridylacryl) amino acid derivatives as potential radiosensitizers against HeLa-S3 cells in vitro. Xin J, Hu B, Li Z, Mi FS, Shen Y. Yao Xue Xue Bao; 1993 Jan 15; 28(2):97-104. PubMed ID: 7687084 [Abstract] [Full Text] [Related] Page: [Next] [New Search]